NCT01236001 Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older Status COMPLETED Phase N/A
NCT01030094 A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy Status COMPLETED Phase N/A
NCT01027715 The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy Status COMPLETED Phase NA
NCT00887861 Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery Status COMPLETED Phase PHASE2
NCT00884052 Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures Status COMPLETED Phase PHASE1/PHASE2
NCT00864006 Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00827320 Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions Status COMPLETED Phase NA
NCT00826865 Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions Status COMPLETED Phase NA
NCT00826787 Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions Status COMPLETED Phase NA
NCT00826722 Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions Status COMPLETED Phase NA
NCT00789113 Determination of Absorption and Elimination of Lamotrigine-XR Status COMPLETED Phase PHASE1/PHASE2
NCT00735527 Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children Status COMPLETED Phase PHASE3
NCT00697918 Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures Status COMPLETED Phase PHASE3
NCT00697762 Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures Status TERMINATED Phase PHASE3
NCT00618046 Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions Status COMPLETED Phase NA
NCT00616863 Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions Status COMPLETED Phase NA